Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Multivalent antimicrobial polymer nanoparticles target mycobacteria and gram-negative bacteria by distinct mechanisms

Tools
- Tools
+ Tools

Richards, Sarah-Jane, Isulfi, Klea, Wilkins, Laura E., Lipecki, Julia, Fullam, Elizabeth and Gibson, Matthew I. (2017) Multivalent antimicrobial polymer nanoparticles target mycobacteria and gram-negative bacteria by distinct mechanisms. Biomacromolecules, 19 (1). pp. 256-264. doi:10.1021/acs.biomac.7b01561

[img]
Preview
PDF
WRAP-multivalent-antimicrobial-polymer-nanoparticles-target-mycobacteria-gram-negative-bacteria-Gibson-2018.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (3572Kb) | Preview
[img] PDF
WRAP-multivalent-antimicrobial-polymer-nanoparticles-mycobacteria-Gibson-2017.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (5Mb)
Official URL: http://dx.doi.org/10.1021/acs.biomac.7b01561

Request Changes to record.

Abstract

Due to the emergence of antimicrobial resistance to traditional small molecule drugs, cationic antimicrobial polymers are appealing targets. Mycobacterium tuberculosis is a particular problem, with multi- and total drug resistance spreading and more than a billion latent infections globally. This study reports nanoparticles bearing variable densities of poly(dimethylaminoethyl methacrylate) and the unexpected and distinct mechanisms of action this multivalent presentation imparts against Escherichia coli verses Mycobacterium smegmatis (model of M. tuberculosis), leading to killing or growth inhibition respectively. A convergent ‘grafting to’ synthetic strategy was used to assemble a 50-member nanoparticle library and using a high- throughput screen identified that only the smallest (2 nm) particles were stable in both saline and complex cell media. Compared to the linear polymers, the nanoparticles displayed 2- and 8-fold enhancements in antimicrobial activity against M. smegmatis and E. coli respectively. Mechanistic studies demonstrated that the antimicrobial particles were bactericidal against E. coli, due to rapid disruption of the cell membranes. Conversely, against M. smegmatis the particles did not lyse the cell membrane but rather had a bacteriostatic effect. These results demonstrate that to develop new polymeric anti-tuberculars the widely assumed, broad spectrum, membrane-disrupting mechanism of polycations must be re-evaluated. It is clear that synthetic nanomaterials can engage in more complex interactions with mycobacteria, which we hypothesise is due to the unique cell envelope at the surface of these bacteria.

Item Type: Journal Article
Subjects: T Technology > TP Chemical technology
Divisions: Faculty of Science > Chemistry
Faculty of Science > Life Sciences (2010- )
Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Antimicrobial polymers, Nanoparticles, Escherichia coli, Mycobacterium tuberculosis
Journal or Publication Title: Biomacromolecules
Publisher: American Chemical Society
ISSN: 1525-7797
Official Date: 1 December 2017
Dates:
DateEvent
1 December 2017Published
1 December 2017Accepted
Volume: 19
Number: 1
Page Range: pp. 256-264
DOI: 10.1021/acs.biomac.7b01561
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIED[ERDF] European Regional Development Fundhttp://dx.doi.org/10.13039/501100008530
BB/M017982/1[BBSRC] Biotechnology and Biological Sciences Research Councilhttp://dx.doi.org/10.13039/501100000268
BB/M01116X/1[BBSRC] Biotechnology and Biological Sciences Research Councilhttp://dx.doi.org/10.13039/501100000268
CRYOMAT 638661H2020 European Research Councilhttp://dx.doi.org/10.13039/100010663
104193/Z/14/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
104193/Z/14/ZRoyal Societyhttp://dx.doi.org/10.13039/501100000288
Early Career FellowshipUniversity of Warwickhttp://dx.doi.org/10.13039/501100000741
RPG–2015 0 194Leverhulme Trusthttp://dx.doi.org/10.13039/501100000275

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us